![]() |
Name |
Penicisulfuranol C
|
Molecular Formula | C21H22N2O9S3 | |
IUPAC Name* |
(1R,9R,13R,15S,16R,19R,20S)-15,16,19-trihydroxy-4,5-dimethoxy-24-methyl-2,21-dioxa-10,11,12-trithia-22,24-diazahexacyclo[11.10.2.01,9.03,8.013,22.015,20]pentacosa-3(8),4,6,17-tetraene-23,25-dione
|
|
SMILES |
CN1C(=O)[C@]23C[C@@]4([C@@H](C=C[C@H]([C@@H]4ON2C(=O)[C@@]15[C@@H](C6=C(O5)C(=C(C=C6)OC)OC)SSS3)O)O)O
|
|
InChI |
InChI=1S/C21H22N2O9S3/c1-22-17(26)20-8-19(28)12(25)7-5-10(24)15(19)32-23(20)18(27)21(22)16(33-35-34-20)9-4-6-11(29-2)14(30-3)13(9)31-21/h4-7,10,12,15-16,24-25,28H,8H2,1-3H3/t10-,12-,15+,16-,19+,20-,21+/m1/s1
|
|
InChIKey |
BFNWYMWIIVLSJC-OFDQUPMBSA-N
|
|
Synonyms |
Penicisulfuranol C; CHEMBL4073777
|
|
CAS | NA | |
PubChem CID | 137640950 | |
ChEMBL ID | CHEMBL4073777 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 542.6 | ALogp: | -0.5 |
HBD: | 3 | HBA: | 12 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 214.0 | Aromatic Rings: | 7 |
Heavy Atoms: | 35 | QED Weighted: | 0.363 |
Caco-2 Permeability: | -5.514 | MDCK Permeability: | 0.00002080 |
Pgp-inhibitor: | 0.715 | Pgp-substrate: | 0.233 |
Human Intestinal Absorption (HIA): | 0.788 | 20% Bioavailability (F20%): | 0.719 |
30% Bioavailability (F30%): | 0.992 |
Blood-Brain-Barrier Penetration (BBB): | 0.141 | Plasma Protein Binding (PPB): | 55.05% |
Volume Distribution (VD): | 1.121 | Fu: | 41.31% |
CYP1A2-inhibitor: | 0.038 | CYP1A2-substrate: | 0.604 |
CYP2C19-inhibitor: | 0.708 | CYP2C19-substrate: | 0.904 |
CYP2C9-inhibitor: | 0.933 | CYP2C9-substrate: | 0.22 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.095 |
CYP3A4-inhibitor: | 0.377 | CYP3A4-substrate: | 0.946 |
Clearance (CL): | 5.72 | Half-life (T1/2): | 0.473 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.156 |
Drug-inuced Liver Injury (DILI): | 0.972 | AMES Toxicity: | 0.602 |
Rat Oral Acute Toxicity: | 0.97 | Maximum Recommended Daily Dose: | 0.309 |
Skin Sensitization: | 0.701 | Carcinogencity: | 0.688 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.774 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003545 | ![]() |
0.929 | D03DIG | ![]() |
0.290 | ||
ENC003544 | ![]() |
0.819 | D0L1JW | ![]() |
0.273 | ||
ENC003539 | ![]() |
0.681 | D04TDQ | ![]() |
0.264 | ||
ENC003546 | ![]() |
0.598 | D0D4HN | ![]() |
0.238 | ||
ENC003659 | ![]() |
0.580 | D0WE3O | ![]() |
0.236 | ||
ENC003549 | ![]() |
0.557 | D06GCK | ![]() |
0.230 | ||
ENC004277 | ![]() |
0.532 | D03SKD | ![]() |
0.227 | ||
ENC003738 | ![]() |
0.512 | D0T6WT | ![]() |
0.227 | ||
ENC003595 | ![]() |
0.469 | D0R9VR | ![]() |
0.227 | ||
ENC004276 | ![]() |
0.464 | D0F7CS | ![]() |
0.226 |